Susan Egaas, MD | |
11511 Ne 10th St, Bellevue, WA 98004-8578 | |
(425) 502-3000 | |
Not Available |
Full Name | Susan Egaas |
---|---|
Gender | Female |
Speciality | Emergency Medicine |
Experience | 39 Years |
Location | 11511 Ne 10th St, Bellevue, Washington |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1730233578 | NPI | - | NPPES |
8356917 | Medicaid | WA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207P00000X | Emergency Medicine | MD00023973 (Washington) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Kaiser Foundation Health Plan Of Washington | 9032022579 | 1480 |
News Archive
The Associated Press reports on the emergence of concerns regarding the health law and drug cost disparities. Meanwhile, other news outlets report on how employers continue to have angst about the measure's price tag.
Bexion Pharmaceuticals LLC announced that the Small Business Administration (SBA) has awarded the Company the prestigious Tibbetts Award, recognizing Bexion as a "Model of Excellence" for the Federal Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs.
Toni Meyer's heart-valve disease was so severe that she suffered shortness of breath even while sitting in a chair. But after Loyola University Hospital physicians replaced her diseased aortic valve in a catheter procedure as part of a clinical trial, Meyer said she is feeling "100 percent better."
Isis Pharmaceuticals, Inc. announced the initiation of a Phase 2 study evaluating ISIS-FXIRx in patients with end-stage renal disease (ESRD) on hemodialysis. In May 2015, Isis entered into an exclusive license agreement with Bayer HealthCare (Bayer) to develop and commercialize ISIS-FXIRx for the prevention of clotting disorders.
Fate Therapeutics, Inc. announced today that it has completed a $30 million Series B financing led by OVP Venture Partners. Joining OVP Venture Partners in the financing is a syndicate of corporate investors, including Astellas Venture Management, Genzyme Ventures and a third undisclosed corporate investor.
› Verified 1 days ago
Entity Name | Kaiser Foundation Health Plan Of Washington |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1396810701 PECOS PAC ID: 9032022579 Enrollment ID: O20031112000454 |
News Archive
The Associated Press reports on the emergence of concerns regarding the health law and drug cost disparities. Meanwhile, other news outlets report on how employers continue to have angst about the measure's price tag.
Bexion Pharmaceuticals LLC announced that the Small Business Administration (SBA) has awarded the Company the prestigious Tibbetts Award, recognizing Bexion as a "Model of Excellence" for the Federal Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs.
Toni Meyer's heart-valve disease was so severe that she suffered shortness of breath even while sitting in a chair. But after Loyola University Hospital physicians replaced her diseased aortic valve in a catheter procedure as part of a clinical trial, Meyer said she is feeling "100 percent better."
Isis Pharmaceuticals, Inc. announced the initiation of a Phase 2 study evaluating ISIS-FXIRx in patients with end-stage renal disease (ESRD) on hemodialysis. In May 2015, Isis entered into an exclusive license agreement with Bayer HealthCare (Bayer) to develop and commercialize ISIS-FXIRx for the prevention of clotting disorders.
Fate Therapeutics, Inc. announced today that it has completed a $30 million Series B financing led by OVP Venture Partners. Joining OVP Venture Partners in the financing is a syndicate of corporate investors, including Astellas Venture Management, Genzyme Ventures and a third undisclosed corporate investor.
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Susan Egaas, MD 11511 Ne 10th St, Bellevue, WA 98004-8578 Ph: (425) 502-3000 | Susan Egaas, MD 11511 Ne 10th St, Bellevue, WA 98004-8578 Ph: (425) 502-3000 |
News Archive
The Associated Press reports on the emergence of concerns regarding the health law and drug cost disparities. Meanwhile, other news outlets report on how employers continue to have angst about the measure's price tag.
Bexion Pharmaceuticals LLC announced that the Small Business Administration (SBA) has awarded the Company the prestigious Tibbetts Award, recognizing Bexion as a "Model of Excellence" for the Federal Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs.
Toni Meyer's heart-valve disease was so severe that she suffered shortness of breath even while sitting in a chair. But after Loyola University Hospital physicians replaced her diseased aortic valve in a catheter procedure as part of a clinical trial, Meyer said she is feeling "100 percent better."
Isis Pharmaceuticals, Inc. announced the initiation of a Phase 2 study evaluating ISIS-FXIRx in patients with end-stage renal disease (ESRD) on hemodialysis. In May 2015, Isis entered into an exclusive license agreement with Bayer HealthCare (Bayer) to develop and commercialize ISIS-FXIRx for the prevention of clotting disorders.
Fate Therapeutics, Inc. announced today that it has completed a $30 million Series B financing led by OVP Venture Partners. Joining OVP Venture Partners in the financing is a syndicate of corporate investors, including Astellas Venture Management, Genzyme Ventures and a third undisclosed corporate investor.
› Verified 1 days ago
Dr. Stephen I Tilghman, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 15325 Se 30th Pl Ste 200, Bellevue, WA 98007 Phone: 425-641-4451 Fax: 425-641-7640 | |
Salma F Gharib, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 11511 Ne 10th St, Bellevue, WA 98004 Phone: 425-502-3000 | |
Stephen W Marshall, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1035 116th Avenue Ne, Bellevue, WA 98004 Phone: 425-688-5759 Fax: 425-688-5101 | |
Marcus A Trione, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1035 116th Avenue Ne, Bellevue, WA 98004 Phone: 425-688-5759 Fax: 425-688-5101 | |
Dr. Lawrence Chu, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 5623 168th Pl Se, Bellevue, WA 98006 Phone: 425-746-3515 | |
Cory Heidelberger, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1035 116th Ave Ne, Bellevue, WA 98004 Phone: 425-688-5759 | |
Dr. Benjamin Andrew Savitch, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1035 116th Ave Ne, Bellevue, WA 98004 Phone: 425-688-5759 |